Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu 1/30/2015 6:13:46 AM
AstraZeneca PLC (AZN)'s Brilinta Boosted by Major Clinical Trial Success 1/14/2015 5:50:03 AM
Ipsen (IPN.PA) To Present Further Data On Recently FDA-Approved Antitumor Therapy, Somatuline® Depot® (Lanreotide), At Gastrointestinal Cancers Symposium 1/13/2015 7:33:08 AM
DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy 1/12/2015 6:58:38 AM
Merck & Co. (MRK)'s Gardasil Not Linked To Multiple Sclerosis, JAMA Reveals 1/7/2015 6:39:21 AM
Cerulean Pharma Inc. (CERU) Announces Publication Describing Synergistic Anti-Tumor Activity Of CRLX101 With Avastin In Advanced Metastatic Ovarian Tumor Models 1/6/2015 11:06:56 AM
Soligenix (SNGX) Announces Publication of Combination Ricin/Anthrax Vaccine Data 12/29/2014 7:38:51 AM
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development 12/19/2014 6:02:39 AM
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer 12/19/2014 6:09:33 AM
FDA Breakthrough Status For Genentech (RHHBY)'s Lucentis 12/16/2014 6:33:51 AM
Pfizer (PFE)'s Top Selling Drug Doesn't Help Patients With Lower Back Pain 12/11/2014 6:08:24 AM
Merck & Co. (MRK)'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients 12/10/2014 7:34:24 AM
Hemispherx Biopharma (HEB) Announces Data Showing Inhibition Of Ebola By Ampligen® Enlarged By Howard University Research 12/9/2014 10:47:49 AM
Amgen (AMGN)'s Kyprolis Delivers In Phase 3 Multiple Myeloma Study 12/8/2014 6:10:35 AM
Gilead Sciences, Inc. (GILD) Presents Follow-Up Data From Zydelig Registrational Studies In Patients With Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 12/8/2014 10:36:47 AM
1234567
//-->